Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert P. Roche Jr currently holds 167,817 shares of ANTARES PHARMA, INC. (ATRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert P. Roche Jr has been a net seller of ATRS stock. They have purchased $91.2K and sold $16.4M worth of shares.
Robert P. Roche Jr's most recent insider trade was on May 24, 2022, when they sold 118,392 shares at $5.60 per share.
Robert P. Roche Jr serves as Executive at ANTARES PHARMA, INC. (ATRS). They have executed 138 insider transactions totaling $16.5M over their tenure at the company.
Robert P. Roche Jr holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert P. Roche Jr has shown a selling trading pattern, with $91.2K in total purchases and $16.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert P. Roche Jr was on Aug 11, 2008, when they sold $1.7M worth of CEPH shares. This transaction involved 21,676 shares at $76.96 per share.
Robert P. Roche Jr currently owns 167,817 shares of ANTARES PHARMA, INC. (ATRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert P. Roche Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert P. Roche Jr has 138 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Robert P. Roche Jr and 40,000+ other insiders.